The administration’s threats stand to chill not only the speech of direct targets but also that of civil servants and employees of contractors who hold clearances.
Latest in Civil Liberties and Constitutional Rights
What’s worrisome about the fight between the Russian government and the Telegram messaging app.
On Friday, April 13, the U.S. District Court for the Western District of Washington ruled that its preliminary injunction on the president’s ban on military service by openly transgender individuals will remain in effect. The court also ruled to make transgender people a protected class, citing the systemic oppression transgender individuals have long faced. The court’s ruling is below:
On March 23, President Trump announced a new policy limiting the ability of transgender people to serve in the U.S. military, based on a recommendation prepared by Defense Secretary James Mattis. Trump's memo, Mattis's memo and the Defense Department study on which Mattis's memo is based are all included below.
With the nominations of Edward Felten and Jane Nitze to serve on the Privacy and Civil Liberties Oversight Board, the White House has done at least one good deed this week.
The Supreme Court is considering a cert petition on the constitutional implications of 3-D printed guns.
Charlottesville demonstrates that Trump is uniquely unwilling to honor and uphold the core conception of full equality for all citizens under the Constitution and the law.
Even if the president makes good on his tweets and directs Secretary Mattis to revise departmental policy to ban transgender service-members, he may not succeed in the courts.
On Tuesday, a civil action was filed by Columbia University’s Knight First Amendment Institute and seven blocked Twitter users, asserting that President Trump and his staff are violating the First Amendment by blocking users on Twitter based on their viewpoints.
The Supreme Court's decision to vacate and remand the cross-border shooting case to the Fifth Circuit avoided the Fourth Amendment question at issue and focused instead on the availability of a Bivens remedy.